Complications of portal triad obstruction and reperfusion in rats. pentadecapeptide BPC 157 counteracts venous and arterial thrombosis and arrhythmias by Vilim Dretar et al.
Complications of portal triad obstruction and reperfusion in rats. pentadecapeptide 
BPC 157 counteracts venous and arterial thrombosis and arrhythmias 
Vilim Dretara, Borna Vrdoljaka, Emma Oreškovića, Oliver Marcel Koltaya, Marko 
Antunovića, Marina Madunića, Josh Frya 
 
aSchool of Medicine University of Zagreb, Department of Pharmacology 
 
Vilim Dretar (0000 – 0002 – 3969 – 712X) , Borna Vrdoljak (0000-0003-2306-8799), Emma 
Orešković (0000-0003-4956-3181), Oliver Marcel Koltay (0000-0003-3820-196X), Marko 
Antunović (0000-0002-3801-5481) , Marina Madunić (0000-0001-9555-3895), Josh Fry 
(0000 – 0003 – 1280 – 7576 
 
Key words: BPC, Thrombosis, Arrhythmias, Obstruction 
We wanted to explore effect of pentadecapeptide BPC 157 therapy in temporary portal triad obstruction 
(PTO) (hepatic artery (HA), portal vein (PV), bile duct occlusion for 30 min in rats), and in reperfusion 
period in post-PTO-period on the counteraction of the Pringle maneuver complications (cloth formation 
in the PV, superior mesenteric vein (SMV), lienal vein (LV), inferior caval vein (ICV) HA, peaked P 
wave and tachycardia). Medication (BPC 157 (10 μg/kg, 10 ng/kg), or saline (5 ml/kg) (controls)) was 
applied as a bath at the clamped area after portal triad clamping in rats with PTO or at the area that used 
to be clamped at 1 min or at 24 h reperfusion time. A period of 30 min of PTO produced thrombosis in 
the ICV, PV, SMV, LV and HA. In BPC 157 treated rats, the weights of the formed clots were smaller. 
PTO rats exhibited peaked P wave values and tachycardia which were absent in BPC 157-treated rats. 
Rats in post-PTO-period, during reperfusion exhibited peaked P wave values and tachycardia. 
Applications of BPC 157 (given at 1 min or at 24 h reperfusion time) resulted in the absence of the 
peaked P waves. Tachycardia was also affected; sinus rhythm appeared in a normal range of heart 
frequency. Confronted with Pringle maneuver and its consequences, BPC 157 therapy distinctively 
mitigates the whole syndrome, involving the counteraction of the course of the thrombosis in both veins 
and arteries, and ECG acute right ventricular overload. 
 
 
 
  
